Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
SDGR
SDGR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SDGR News
11 Stocks That Have Plummeted and Appear to Be Good Investment Opportunities
6d ago
Barron's
Salesforce Shares and 10 Other Stocks That Have Plummeted and Appear to Be Good Investments
6d ago
Barron's
VentriPoint Diagnostics Accelerates Commercialization of Cardiac Imaging Technology
Jan 29 2026
PRnewswire
VentriPoint Diagnostics Accelerates Commercialization of Cardiac Imaging Technology
Jan 29 2026
Newsfilter
Schrodinger Partners with Eli Lilly to Launch AI Drug Design Platform TuneLab
Jan 09 2026
Newsfilter
Pinnacle Financial Partners Trading 32.3% Below Fair Value Amid Growth Prospects
Dec 26 2025
Yahoo Finance
Avant Technologies Strengthens Clinical Validation for α-Klotho Therapy
Dec 09 2025
PRnewswire
Avant Technologies Strengthens Clinical Validation of α-Klotho, Advancing Cell Therapy Progress
Dec 09 2025
Newsfilter
Analysts Predict HAPS Will Hit $37
Nov 11 2025
NASDAQ.COM
Schrödinger Revises 2025 Software Growth Forecast to 8%-13% Due to Pharma Scale-Up Delays and Emphasis on Operational Efficiency
Nov 05 2025
SeekingAlpha
Will Schrödinger (SDGR) Maintain Its AI Advantage in Drug Discovery Ahead of Q3 Results?
Oct 25 2025
Yahoo Finance
Schrodinger (SDGR) Shows Promise: Will Its 13.8% Surge Lead to Further Gains?
Oct 21 2025
NASDAQ.COM
SPSM Aims for $53: Understanding the Components Behind the Goal
Oct 09 2025
NASDAQ.COM
Goldman Sachs Begins Coverage of Schrodinger with a Neutral Rating and Sets Price Target at $19
Sep 30 2025
Benzinga
Schrödinger Announces Inducement Grants in Compliance with Nasdaq Listing Rule 5635(c)(4)
Sep 18 2025
Newsfilter
Insights from 4 Analyst Ratings on Schrodinger
Aug 18 2025
Benzinga
Show More News
